FIELD: medicine, immunology. SUBSTANCE: invention reports about compositions and methods for enhancement of cytocide immune responses directed against preliminary taken cells type in mammals. Methods and compositions are based on the combination of immunoconjugate of type antibody-cytokine and angiogenesis inhibitor. In administration to mammal the immunoconjugate induces the response against preliminary taken cells type, for example, cancer cells that as result of synergetic effect with angiogenesis inhibitor exceeds the immune response induced by a single immunoconjugate. Methods and compositions are useful especially for eradication solid tumors or virus-infected mammalian cells. EFFECT: expanded assortment of immunomodulating agents. 27 cl, 5 dwg
Title |
Year |
Author |
Number |
ENHANCEMENT OF IMMUNE RESPONSE WHEREIN FUSED PROTEIN ANTIBODY-CYTOKINE IS MEDIATOR BY COMBINED TREATMENT WITH AGENTS INCREASING IMMUNOCYTOKINE ABSORPTION |
2001 |
- Gilliz Stiven D.
- Lan' Jan'
- Kholden Sil'Vija A.
|
RU2272644C2 |
HOMODIMERIC FUSED PROTEIN WITH ACTIVITY OF ANGIOGENESIS INHIBITOR (VARIANTS), DNA MOLECULE ENCODING HOMODIMERIC FUSED PROTEIN, VECTOR FOR EXPRESSION OF HOMODIMERIC FUSED PROTEIN, METHOD FOR TRANSFECTION OF MAMMALIAN CELL AND METHOD FOR PREPARING HOMODIMERIC FUSED PROTEIN |
1999 |
- Lo Kin-Ming
- Li Jue
- Dzhilliz Stefen D.
|
RU2240328C2 |
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 |
2003 |
- Dzhilliz Stefen D.
- Lo Kin Ming
|
RU2366664C2 |
FUSED PROTEINS WITH IMMUNOGLOBULIN FC-FRAGMENT FOR ENHANCING IMMUNOGENICITY OF PROTEIN AND PEPTIDE ANTIGENS |
2000 |
- Dzhilliz Stefen D.
- Lo Kin Ming
- Vesolovski Dzhon S. Dzhr.
|
RU2248214C2 |
NRR Notch1 ANTIBODIES AND METHODS OF APPLICATION THEREOF |
2008 |
|
RU2476443C2 |
ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) |
2008 |
- Fa Zhermejn
- Li Chingvehj V.
|
RU2514148C2 |
HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED DEATH 1 (PD-1) PROTEIN AND CANCER TREATMENT METHOD USING ANTI-PD-1-ANTIBODIES SEPARATELY OR COMBINED WITH OTHER IMMUNOTHERAPEUTIC AGENTS |
2013 |
- Korman Alan Dzh.
- Srinivasan Mokhan
- Van Chanyuj
- Selbi Mark Dzh.
- Chen Bin
- Kardarelli Zhozefin M.
|
RU2599417C2 |
IMMUNOCONJUGATES, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION |
1995 |
- Vol'Fgang Khel'Tser
- Ilka Fon Khoegen
- Vol'Fgang Shtrittmatter
- Zigfrid Mattsku
|
RU2157701C2 |
EGFL7 ANTIBODIES AND METHODS OF APPLICATION THEREOF |
2007 |
- E Vehjlan'
- Shmidt Majke
- Khongo Dzho-Ehnn
- U Jan'
|
RU2415870C2 |
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR PROGRAMMED CELL DEATH 1 (PD1) PROTEIN AND METHODS OF TREATING CANCER WITH USING ANTI-PD1 ANTIBODIES EITHER INDIVIDUALLY, OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS |
2006 |
- Korman Alan Dzh.
- Srinivasan Mokhan
- Van Chanjuj
- Selbi Mark Dzh.
- Chehn' Bin
- Kardarelli Zhozefin M.
- Khuan Khajchun'
|
RU2494107C2 |